PMID- 31884703
OWN - NLM
STAT- MEDLINE
DCOM- 20201119
LR  - 20210402
IS  - 1475-6773 (Electronic)
IS  - 0017-9124 (Print)
IS  - 0017-9124 (Linking)
VI  - 55
IP  - 2
DP  - 2020 Apr
TI  - Evaluating the role of Section 1115 waivers on Medicaid coverage and utilization 
      of opioid agonist therapy among substance use treatment admissions.
PG  - 232-238
LID - 10.1111/1475-6773.13250 [doi]
AB  - OBJECTIVE: To examine the impact of Section 1115 waivers on Medicaid coverage and 
      opioid agonist therapy (OAT) utilization among substance use treatment 
      admissions. DATA SOURCE: Treatment Episode Data Set-Admissions (TEDS-A) 
      (2001-2012). STUDY DESIGN: We examined effects of 1115 waiver implementation on 
      proportions of substance use treatment admissions with Medicaid and receiving 
      OAT, using random intercept linear regression. PRINCIPAL FINDINGS: 1115 waiver 
      implementation was associated with an average of a 6 percentage point increase in 
      proportion of all admissions with Medicaid, and 4 percentage point increase among 
      opioid outpatient admissions. Implementation was not associated with change in 
      proportion of opioid outpatient admissions receiving OAT. CONCLUSIONS: 1115 
      waivers influence Medicaid coverage among substance use treatment admissions. The 
      findings improve our understanding of how state policies impact substance use 
      treatment utilization.
CI  - (c) Health Research and Educational Trust.
FAU - Tormohlen, Kayla N
AU  - Tormohlen KN
AUID- ORCID: 0000-0002-4790-4731
AD  - Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, 
      Baltimore, Maryland.
FAU - Krawczyk, Noa
AU  - Krawczyk N
AD  - Department of Population Health, New York University School of Medicine, New 
      York, New York.
FAU - Feder, Kenneth A
AU  - Feder KA
AD  - Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, 
      Baltimore, Maryland.
FAU - Riehm, Kira E
AU  - Riehm KE
AD  - Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, 
      Baltimore, Maryland.
FAU - Crum, Rosa M
AU  - Crum RM
AD  - Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, 
      Baltimore, Maryland.
AD  - Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, 
      Baltimore.
AD  - Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins 
      Bloomberg School of Public Health, Baltimore, Maryland.
AD  - Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School 
      of Medicine, Baltimore, Maryland.
FAU - Mojtabai, Ramin
AU  - Mojtabai R
AD  - Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, 
      Baltimore, Maryland.
AD  - Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School 
      of Medicine, Baltimore, Maryland.
LA  - eng
GR  - F31 DA044699/DA/NIDA NIH HHS/United States
GR  - CIHR/Canada
GR  - T32 DA007292/DA/NIDA NIH HHS/United States
GR  - F31 DA047021/DA/NIDA NIH HHS/United States
GR  - R01 DA039863/DA/NIDA NIH HHS/United States
GR  - T32 MH014592/MH/NIMH NIH HHS/United States
PT  - Journal Article
PT  - Research Support, N.I.H., Extramural
PT  - Research Support, Non-U.S. Gov't
DEP - 20191229
PL  - United States
TA  - Health Serv Res
JT  - Health services research
JID - 0053006
RN  - 0 (Analgesics, Opioid)
SB  - IM
MH  - Adult
MH  - Aged
MH  - Aged, 80 and over
MH  - Analgesics, Opioid/*economics/*therapeutic use
MH  - Female
MH  - Health Policy
MH  - Health Services Accessibility/legislation & jurisprudence/statistics & numerical 
      data
MH  - Humans
MH  - Male
MH  - Medicaid/*economics/*legislation & jurisprudence/statistics & numerical data
MH  - Middle Aged
MH  - Opiate Substitution Treatment/*economics/*statistics & numerical data
MH  - Opioid-Related Disorders/*drug therapy/*economics
MH  - United States
PMC - PMC7080398
OTO - NOTNLM
OT  - Section 1115 waiver
OT  - medicaid
OT  - opioid agonist therapy
OT  - opioid use treatment
OT  - substance use treatment
COIS- The authors declare that they have no conflicts of interest.
EDAT- 2019/12/31 06:00
MHDA- 2020/11/20 06:00
PMCR- 2021/04/01
CRDT- 2019/12/30 06:00
PHST- 2019/12/31 06:00 [pubmed]
PHST- 2020/11/20 06:00 [medline]
PHST- 2019/12/30 06:00 [entrez]
PHST- 2021/04/01 00:00 [pmc-release]
AID - HESR13250 [pii]
AID - 10.1111/1475-6773.13250 [doi]
PST - ppublish
SO  - Health Serv Res. 2020 Apr;55(2):232-238. doi: 10.1111/1475-6773.13250. Epub 2019 
      Dec 29.